mangalore today
name
name
name
Friday, October 30
Abish Buildersnamename

 

India reports single-day rise of 86,961 cases, 1,130 deaths


Mangalore Today News Network

New Delhi, Sep 21, 2020: India’s coronavirus tally has crossed 54 lakh as the country continued to report the highest single-day caseload in the world since early August. As of now, India only lags behind the United States in terms of total cases reported so far. But there is good news. According to the Union Health Ministry, India is now the country with the highest number of recoveries, accounting for close to 19 per cent of all global recoveries. The country’s death toll in contrast to the sheer number of cases is also low at 86,572. The fatality rate in India is one of the lowest in the world at 1.6 per cent. Meanwhile, the DGCI has approved the commercial launch of Feluda - an advanced CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Covid-19 test launched by Tata. The Tata CRISPR test matches accuracy levels of traditional RT-PCR tests with quicker turnaround time.

 

covid21sep20


India has reported a single-day rise of 86,961 coronavirus cases and 1,130 deaths on Monday. Active cases in India currently stand at 10,03,299 while nearly 44 lakh people have recovered after getting infected. At least 87,882 people have died due to Covid-19 in India.

Nearly 6.50 crore Covid-19 samples have been tested in India, according to the Indian Council of Medical Research. According to ICMR, 6,43,92,594 have been tested up to September 20 including 7,31,534 samples tested on Sunday.

Schools and colleges in Assam are reopening today after months due to the ongoing Covid-19 pandemic. A student told news agency ANI that she is happy with the government’s decision to reopen schools and colleges. "We will try and follow all Covid-19 guidelines while attending the classes," she said.

North Indian states could face a major problem later this month when stubble burning starts ahead of the Rabi crop sowing season, according to experts.

There are several challenges that India is likely to face even after medical experts give a green signal for the mass production of a Covid-19 vaccine. Dr Harsh Vardhan, India’s Union Health Minister, recently informed Parliament that a vaccine may be developed only by 2021. However, the challenges do not end there. Harsh Vardhan also said that it would take time to make the vials available to the public in large quantities. Extraordinary logistics would also be required to vaccinate the country’s 1.3 billion people, especially those who live in remote parts like North-East and Ladakh in the Himalayas. READ MORE

Even as India continues to register the highest number of daily Covid-19 cases in the world, there is something that the country can cheer about. With 19 per cent of all global recoveries, India now has the highest number of total coronavirus recoveries in the world. Another silver lining is the low fatality rate, which has now fallen to 1.6 per cent. However, the rising number of cases in rural areas still remains a concern for the government and it now aims to further ramp up testing capabilities for early detection and limitation of cases. India has so far recorded 54 lakh cases, making it the second worst-hit country in the world behind the US. The country has been reporting the highest number of daily cases since early August.

As India’s Covid-19 tally crosses 54 lakh, the government aims to increase detection of cases in the country using the new and improved ’Feluda’ tests launched by Tata. The DGCI has approved the commercial launch of Feluda, which is an advanced CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Covid-19 test launched by Tata. The Tata CRISPR test matches accuracy levels of traditional RT-PCR tests with quicker turnaround time.

 

courtesy:IndiaToday


Write Comment | E-Mail To a Friend | Facebook | Twitter | Print
Write your Comments on this Article
Your Name
Native Place / Place of Residence
Your E-mail
Your Comment
You have characters left.
Security Validation
Enter the characters in the image above